Maze Therapeutics’ Chief Medical Officer Sold 100% of His Direct Holdings. Here’s What This Means for Investors.

Key PointsChief Medical Officer Harold Bernstein sold 15,000 company shares for a transaction value of ~$442,000 at around $29.46 per share on April 1, 2026.